Home › Autism Spectrum Disorder › NCT04446442

Cerebellar tDCS in Children With Autism Spectrum Disorder

Biologic Effects and Efficacy of Cerebellar tDCS in Children With Autism Spectrum Disorder

Who can join

Ages 4 to 17 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* 4-17 years old
* Diagnosed with ASD and ADOS-2
* IQ Score no less than 70 (1.5 Standard Deviations below the mean)
* Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences)

Exclusion Criteria:

* Brain implants, metal implants, pacemakers, or biomedical devices
* Diagnosis of epilepsy
* Hearing or visual impairments
* History of brain injury
* Known brain abnormalities not associated with ASD

About the study

The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.

What is being tested

• tDCS (device)

Sponsor: University of Texas Southwestern Medical Center · Participants: 60 · Started: Jun 4, 2019

Contact the study team

• Peter Tsai, MD, PhD · Phone: 214-648-3577
• Amy Magallanes · Phone: 214-648-5155

Official record on ClinicalTrials.gov — NCT04446442

Locations in the U.S.

Conditions

• Autism Spectrum Disorder

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.